Ann: Cann Group FY23 unaudited revenue results, page-8

  1. 2,100 Posts.
    lightbulb Created with Sketch. 659
    It turned up in the facilities of the second largest generic pharmaceuticals company in the world who said they'll keep it and in return give ECS the business to supply them with all of the medicinal cannabis product they require.

    The CEO of CAN said he wants to see more involvement from big Pharma in the local industry, perhaps this is a good example.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.5¢
Change
0.001(7.14%)
Mkt cap ! $9.769M
Open High Low Value Volume
1.4¢ 1.6¢ 1.4¢ $25.02K 1.687M

Buyers (Bids)

No. Vol. Price($)
3 1048333 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.6¢ 2864001 8
View Market Depth
Last trade - 15.55pm 31/07/2025 (20 minute delay) ?
CAN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.